Z

Zhejiang Tianyu Pharmaceutical Co Ltd
SZSE:300702

Watchlist Manager
Zhejiang Tianyu Pharmaceutical Co Ltd
SZSE:300702
Watchlist
Price: 17.31 CNY 2.43%
Market Cap: 6B CNY
Have any thoughts about
Zhejiang Tianyu Pharmaceutical Co Ltd?
Write Note

Zhejiang Tianyu Pharmaceutical Co Ltd
Other Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Zhejiang Tianyu Pharmaceutical Co Ltd
Other Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Equity CAGR 3Y CAGR 5Y CAGR 10Y
Z
Zhejiang Tianyu Pharmaceutical Co Ltd
SZSE:300702
Other Equity
ÂĄ0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Other Equity
ÂĄ136.9m
CAGR 3-Years
N/A
CAGR 5-Years
14%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Other Equity
ÂĄ2.3m
CAGR 3-Years
-78%
CAGR 5-Years
-58%
CAGR 10-Years
-35%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Other Equity
ÂĄ18.5m
CAGR 3-Years
N/A
CAGR 5-Years
44%
CAGR 10-Years
N/A
Yunnan Baiyao Group Co Ltd
SZSE:000538
Other Equity
-ÂĄ36.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Other Equity
ÂĄ1.4m
CAGR 3-Years
-23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Zhejiang Tianyu Pharmaceutical Co Ltd
Glance View

Market Cap
6B CNY
Industry
Pharmaceuticals

Zhejiang Tianyu Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of chemical raw materials and intermediates. The company is headquartered in Taizhou, Zhejiang and currently employs 4,991 full-time employees. The company went IPO on 2017-09-19. The firm operates three segments. The Pharmaceutical Intermediates segment include hypertension drugs raw materials, anti-asthma drugs raw materials and anticoagulant drugs raw materials. The Active Pharmaceutical Ingredients (API) segment is engaged in production of high blood pressure drug intermediates, anti-asthma drug intermediates and antiviral drug intermediates. The firm also operates Other segment. The firm sells its products to both domestic and international markets, including Europe, the United States, Japan, South Korea and so on.

Intrinsic Value
20.88 CNY
Undervaluation 17%
Intrinsic Value
Price
Z

See Also

What is Zhejiang Tianyu Pharmaceutical Co Ltd's Other Equity?
Other Equity
0 CNY

Based on the financial report for Sep 30, 2024, Zhejiang Tianyu Pharmaceutical Co Ltd's Other Equity amounts to 0 CNY.

Back to Top